Home
HRMY
HRMY News

Latest Harmony Biosciences Holdings Inc. (HRMY) News on October 20, 2025

Harmony Biosciences (HRMY): Assessing Valuation After RECONNECT Trial Disappointment for ZYN002 in Fragile X Syndrome

Simply Wall St.

18 days ago

Harmony Biosciences (HRMY): Assessing Valuation After RECONNECT Trial Disappointment for ZYN002 in Fragile X Syndrome

Harmony Biosciences Holdings (HRMY) Reports Impressive Earnings Growth

Simply Wall St.

a month ago

Harmony Biosciences Holdings (HRMY) Reports Impressive Earnings Growth

Argus Research

4 months ago

HRMY: What does Argus have to say about HRMY?

Needham Reiterates a Buy Rating on Harmony Biosciences (HRMY)

Insider Monkey

4 months ago

Needham Reiterates a Buy Rating on Harmony Biosciences (HRMY)

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

Business Wire

4 months ago

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

Argus Research

4 months ago

HRMY: Rating decreased to a HOLD

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Insider Monkey

4 months ago

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Harmony Biosciences settles generic drug litigation, strengthens patent

TipRanks

4 months ago

Harmony Biosciences settles generic drug litigation, strengthens patent

MT Newswires

4 months ago

Harmony Biosciences, Lupin Settle Lawsuit Over Generic Version of Narcolepsy Drug

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation

Business Wire

4 months ago

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation

Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Business Wire

5 months ago

Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Argus Research

5 months ago

HRMY: Raising target price to $46.00

MT Newswires

5 months ago

Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating

Argus Research

5 months ago

HRMY: Raising target price to $45.00

We Like Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings For More Than Just Statutory Profit

Simply Wall St.

5 months ago

We Like Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings For More Than Just Statutory Profit

Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations

Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com

5 months ago

Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Harmony Biosciences Holdings Inc Earnings Call

Argus Research

5 months ago

HRMY: Raising target price to $42.00

MT Newswires

5 months ago

Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated

Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates

Zacks

5 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates

Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance

Business Wire

5 months ago

Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance

Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Report Preview: What to Look For

GuruFocus.com

6 months ago

Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Report Preview: What to Look For

Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again

Zacks

6 months ago

Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks

6 months ago

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

Business Wire

6 months ago

Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

MT Newswires

6 months ago

UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating

Argus Research

6 months ago

HRMY: Raising target price to $38.00

MT Newswires

6 months ago

BofA Cuts Price Target on Harmony Biosciences to $32 From $33

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Zacks

6 months ago

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Argus Research

6 months ago

HRMY: What does Argus have to say about HRMY?

Argus Research

6 months ago

HRMY: Lowering target price to $37.00

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Business Wire

6 months ago

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Insider Monkey

7 months ago

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors

Business Wire

7 months ago

Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors

Argus Research

7 months ago

HRMY: Lowering target price to $42.00

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode?

Insider Monkey

7 months ago

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode?

Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Business Wire

7 months ago

Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Argus Research

7 months ago

HRMY: Lowering target price to $43.00

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

Business Wire

7 months ago

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Zacks

7 months ago

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

MT Newswires

7 months ago

Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating

Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts

Insider Monkey

7 months ago

Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts

Argus Research

8 months ago

HRMY: Rating increased to a BUY

Harmony Biosciences to Participate in Upcoming Investor Conferences

Business Wire

8 months ago

Harmony Biosciences to Participate in Upcoming Investor Conferences

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.

8 months ago

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

MT Newswires

8 months ago

UBS Adjusts Price Target on Harmony Biosciences to $55 From $56, Keeps Buy Rating

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks

8 months ago

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Harmony Biosciences Holdings Inc Earnings Call

Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com

8 months ago

Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...

Argus Research

8 months ago

HRMY: Lowering target price to $39.00

Harmony Biosciences (HRMY) Q4 2024 Earnings Call Transcript

Motley Fool

8 months ago

Harmony Biosciences (HRMY) Q4 2024 Earnings Call Transcript

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now?

Insider Monkey

8 months ago

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now?

Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates

Zacks

8 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates

MT Newswires

8 months ago

Harmony Biosciences' Q4 Adjusted Earnings, Net Product Revenue Rise

Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs

Business Wire

8 months ago

Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs

Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Reports Q4 2024 Result

GuruFocus.com

8 months ago

Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Reports Q4 2024 Result

Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now?

Insider Monkey

8 months ago

Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now?

Harmony Biosciences (HRMY) Upgraded to Strong Buy: Here's Why

Zacks

8 months ago

Harmony Biosciences (HRMY) Upgraded to Strong Buy: Here's Why

5 High Earnings Yield Value Stocks to Buy Amid Market Volatility

Zacks

8 months ago

5 High Earnings Yield Value Stocks to Buy Amid Market Volatility

MT Newswires

8 months ago

Deutsche Bank Adjusts Harmony Biosciences Price Target to $52 From $55, Maintains Buy Rating

MT Newswires

8 months ago

Mizuho Adjusts Price Target on Harmony Biosciences to $42 From $52, Keeps Outperform Rating

Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug

Investor's Business Daily

8 months ago

Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Benzinga

8 months ago

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

MT Newswires

8 months ago

Harmony Biosciences Receives US FDA's Refusal to File Letter Related to Application for Pitolisant in Idiopathic Hypersomnia

Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia

Business Wire

8 months ago

Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia

Argus Research

8 months ago

HRMY: Raising target price to $41.00

Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Business Wire

8 months ago

Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

HRMY or ONC: Which Is the Better Value Stock Right Now?

Zacks

8 months ago

HRMY or ONC: Which Is the Better Value Stock Right Now?

Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now

Zacks

8 months ago

Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now

Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now

Insider Monkey

8 months ago

Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now

MT Newswires

8 months ago

Deutsche Bank Initiates Coverage on Harmony Biosciences With Buy Rating, $55 Price Target

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Zacks

8 months ago

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?

Zacks

8 months ago

RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Zacks

8 months ago

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Argus Research

9 months ago

HRMY: Raising target price to $41.00

MT Newswires

9 months ago

BofA Adjusts Price Target on Harmony Biosciences to $31 From $32

Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know

Zacks

9 months ago

Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know

Harmony Biosciences Stock Scores 80-Plus RS Rating

Investor's Business Daily

9 months ago

Harmony Biosciences Stock Scores 80-Plus RS Rating

HRMY vs. RGEN: Which Stock Is the Better Value Option?

Zacks

9 months ago

HRMY vs. RGEN: Which Stock Is the Better Value Option?

Argus Research

9 months ago

HRMY: Lowering target price to $40.00

MT Newswires

9 months ago

Harmony Biosciences Holdings Insider Sold Shares Worth $551,575, According to a Recent SEC Filing

Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?

Simply Wall St.

9 months ago

Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?

Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes

Zacks

9 months ago

Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes

MT Newswires

9 months ago

Harmony Biosciences Holdings Insider Sold Shares Worth $774,245, According to a Recent SEC Filing

4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency

Zacks

9 months ago

4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency

Argus Research

9 months ago

HRMY: Raising target price to $42.00

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks

9 months ago

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge

Zacks

9 months ago

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%

Zacks

9 months ago

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%

Harmony Biosciences price target raised to $32 from $31 at BofA

TipRanks

9 months ago

Harmony Biosciences price target raised to $32 from $31 at BofA

Argus Research

9 months ago

HRMY: Raising target price to $38.00

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Zacks

9 months ago

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Genmab (GMAB) Right Now?

Zacks

9 months ago

Are Investors Undervaluing Genmab (GMAB) Right Now?

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential

Insider Monkey

9 months ago

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

Investor's Business Daily

9 months ago

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

MT Newswires

9 months ago

Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Business Wire

9 months ago

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Argus Research

10 months ago

HRMY: Raising target price to $37.00

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR Newswire

10 months ago

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Share on Social Networks: